Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer
American Journal of Obstetrics and Gynecology(2021)
摘要
Prediction of response to hormonal treatment in endometrial cancer improves substantially with a 50% cut-off level for PR-IHC and by applying a sequential test algorithm using PR-IHC and ER pathway activity scores. Results need to be validated in the PROMOTE-prospective study.
更多查看译文
关键词
aromatase inhibitors,estrogen receptor pathway activity,progesterone receptor,progestin therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要